Vensica Therapeutics is a clinical-stage biopharmaceutical company. It develops minimally invasive solutions in urology using properties of therapeutic ultrasound to deliver botulinum toxin A to the bladder indications such as overactive and neurogenic bladder and painful bladder syndrome.